Thermo Fisher and Symphogen continue work to support the development of innovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows
A new method of applying machine learning concepts to the tandem mass spectrometry process could improve the flow of information in the development of new drugs